Cefepime

Maxipime

1GM BASE/VIAL, 2GM BASE/VIAL, 500MG BASE/VIAL injectableÉtats-UnisNon commercialiséAutorisé le 18 janv. 1996

Dans d’autres pays

Les mêmes substances actives dans d’autres registres, en commençant par la même marque.

Maxipime for Injection-PWS IV 2GMCanada · 2 G / VIAL · Powder For Solution · Bristol-Myers Squibb CanadaMême marque
Maxipime for Injection -PWS IV IM 1GCanada · 1 G / VIAL · Powder For Solution · Bristol-Myers Squibb CanadaMême marque
Maxipime 1 G VialArabie saoudite · Bristol-Myers SquibbMême marque
Maxipime 2 G VialArabie saoudite · Bristol-Myers SquibbMême marque
CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1 g/vialSingapour · 1000 mg/vial · injection, powder, for solution · Fresenius Kabi (Singapore) Pte LTDMême dosage et même forme
CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vialSingapour · 2000 mg/vial · injection, powder, for solution · Fresenius Kabi (Singapore) Pte LTD

Conditionnement	Code	Statut
CEFEPIME HYDROCHLORIDE EQ 2GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA050679-003	Discontinued
CEFEPIME HYDROCHLORIDE EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA050679-001	Discontinued
CEFEPIME HYDROCHLORIDE EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA050679-002	Discontinued